0
RNA-based therapy shows promise for treating genetic diseases caused by nonsense mutations
Researchers at the University of Toronto developed a new RNA-based therapeutic strategy using chemically modified suppressor tRNAs delivered via lipid nanoparticles, showing efficacy in preclinical tests for cystic fibrosis and muscular dystrophy.